USANA Health Sciences Inc (USNA)
Interest coverage
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 102,715 | 108,813 | 170,699 | 178,455 | 150,562 |
| Interest expense | US$ in thousands | 262 | 192 | 57 | 507 | 66 |
| Interest coverage | 392.04 | 566.73 | 2,994.72 | 351.98 | 2,281.24 |
December 31, 2023 calculation
Interest coverage = EBIT ÷ Interest expense
= $102,715K ÷ $262K
= 392.04
The interest coverage ratio for USANA Health Sciences Inc has fluctuated over the past five years. In 2023, the interest coverage ratio was 392.04, indicating the company's ability to cover its interest expenses by its earnings before interest and taxes (EBIT) improved compared to the previous year. In 2022, the ratio stood at 566.73, demonstrating a strong ability to meet interest obligations comfortably.
However, the interest coverage ratio experienced significant fluctuations in 2021 and 2019. In 2021, the ratio sharply increased to 2,994.72, signifying a substantial improvement in the company's ability to cover its interest expenses, possibly due to a significant increase in EBIT. Conversely, in 2019, the ratio was 2,281.24, indicating another year of robust interest coverage.
Overall, the interest coverage ratio for USANA Health Sciences Inc has shown a mix of strong and fluctuating performance over the past five years, with the company generally demonstrating a solid ability to meet its interest obligations with its operating income.